Debt-to-equity of HCW Biologics Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
HCW Biologics Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • HCW Biologics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -734%, a 141% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

HCW Biologics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -734% -2527% -141% 30 Sep 2025
Q2 2025 -542% -747% -364% 30 Jun 2025
Q1 2025 -448% -527% -663% 31 Mar 2025
Q4 2024 -898% -947% -1919% 31 Dec 2024
Q3 2024 1793% +1758% +5015% 30 Sep 2024
Q2 2024 205% +177% +624% 30 Jun 2024
Q1 2024 80% +60% +316% 31 Mar 2024
Q4 2023 49% +37% +313% 31 Dec 2023
Q3 2023 35% +28% +377% 30 Sep 2023
Q2 2023 28% 30 Jun 2023
Q1 2023 19% 31 Mar 2023
Q4 2022 12% 31 Dec 2022
Q3 2022 7.4% 30 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.